1b1a17a3-figure-01 (C22b0765 1777 4001 836a 2684daf2a35b 01)
Spironolactone
Product Images NDC 42254-183
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 42254-183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1b1a17a3-figure-02 (C22b0765 1777 4001 836a 2684daf2a35b 02)
1b1a17a3-figure-03 (C22b0765 1777 4001 836a 2684daf2a35b 03)
This appears to be a table or graph showing 2 subgroups (possibly related to a medical study or clinical trial) and the corresponding results for the effectiveness of Spironolactone versus Placebo. The measurements appear to be given in terms of HR (hazard ratio) and 95% CI (confidence interval). However, without more context or additional information, it is difficult to provide a more specific description.*
1b1a17a3-figure-04 (C22b0765 1777 4001 836a 2684daf2a35b 04)
Spironolactone 25mg (C22b0765 1777 4001 836a 2684daf2a35b 05)
This is a description of a medicine called Spironolactone 25mg, in a package of 30 tablets manufactured by Actavis Elizabeth LLC. The package contains tablets made of Spironolactone, USP 28mg. The product ID is QS018330. There is also a warning to keep the medicine out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
